The Food and Drug Administration (FDA) on Wednesday confirmed there is an Adderall shortage in the United States amid reports of people having prescriptions for the ADHD drug.
The FDA “is in frequent communication with all manufacturers of amphetamine mixed salts, and one of those companies, Teva, is experiencing ongoing intermittent manufacturing delays,” a statement from the agency said, referring to precursors to manufacture Adderall—a drug mixture composed of equal parts racemic amphetamine and dextroamphetamine.
